Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With Psoriasis
Status: Enrolling
Updated:  12/31/1969
PAREXEL-Phase 1 Baltimore Harbor Hospital Center
mi
from
Baltimore, MD
A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis
A Phase 1 Randomized, Placebo-Controlled Study of LY3316531 in Healthy Subjects and an Open-Label, Single-Dose Study in Patients With Psoriasis
Status: Enrolling
Updated: 12/31/1969
PAREXEL-Phase 1 Baltimore Harbor Hospital Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Glendale, AZ
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Glendale, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Site 157
mi
from
Bryant, AR
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Site 157
mi
from
Bryant, AR
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rogers, AR
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fountain Valley, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fremont, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fremont, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Murrieta, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Santa Rosa, CA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miramar, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miramar, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Port Richey, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Orange Park, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Orange Park, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Sweetwater, FL
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Sweetwater, FL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nampa, ID
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nampa, ID
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Albany, IN
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Overland Park, KA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Baton Rouge, LA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Clinton Township, MI
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clinton Township, MI
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fridley, MN
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Stony Brook, NY
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
High Point, NC
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Beachwood, OH
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Johnston, RI
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Johnston, RI
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mount Pleasant, SC
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rapid City, SD
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rapid City, SD
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bellaire, TX
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects With Moderate-t0-Severe Plaque Psoriasis (AFFIRM)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials